A study to determine clinical effectiveness of golimumab in biologic inadequate responder patients with Rheumatoid arthritis, Spondyloarthritis, and Psoriatic arthritis using data from GISEA is a national registry
Latest Information Update: 23 Jul 2021
At a glance
- Drugs Golimumab (Primary)
- Indications Psoriatic arthritis; Rheumatoid arthritis; Spondylarthritis
- Focus Therapeutic Use
Most Recent Events
- 23 Jul 2021 New trial record